| Name | Cyromazine |
| Description | Cyromazine (CGA-72662) is an ectoparasiticide. Insect growth regulator. Specific activity against dipterous larvae. Cyromazine is a fda approved for use in livestock. |
| In vitro | In both plants and animals, Cyromazine undergoes dealkylation metabolism and, through environmental degradation, forms melamine. |
| In vivo | Cyromazine may act at certain stages of cuticle sclerotization, with little to no effect on dihydrofolate reductase and the activity of aminomethylphosphonic acid. It alters the percentage or total content of phenylalanine and tyrosine amino acids in the pupal exoskeleton cuticle, resulting in larvae exhibiting typical signs of Cyromazine intoxication. The mechanism of action likely involves inhibiting the synthesis of chitin and scleroprotein. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 1 mg/mL (6.02 mM), Sonication is recommended. Ethanol : 2 mg/mL (12.04 mM), Sonication is recommended. DMSO : 60 mg/mL (361.05 mM), Sonication is recommended.
|
| Keywords | Inhibitor | inhibit | EndogenousMetabolite | Endogenous Metabolite | Cyromazine | CGA72662 | CGA 72662 |
| Inhibitors Related | Sucrose | Acetaminophen | Daidzein | Guanidine hydrochloride | Fumaric acid | Ferulic Acid | L-Methionine | Formamide | Glycerol | Thymidine | Naringin | 3-Indoleacetic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Pesticide Compound Library | Anti-Parasitic Compound Library | Bioactive Compound Library | Toxic Compound Library | Natural Product Library | Drug Repurposing Compound Library | Natural Product Library for HTS | RO5 Drug-like Natural Product Library | Anti-infective Natural Product Library | Bioactive Compounds Library Max | Anti-Infection Compound Library |